drug pricing

Research in Review
Insulin Pump Therapy Inferior to Insulin Injections in Cost-Effectiveness
06/23/2017
JCP Editors
Continuous subcutaneous insulin infusion (CSII) is associated with increased hypoglycemia encounters and health care expenditures, according to research published in the American Journal of Managed Care (June 21,...
Continuous subcutaneous insulin infusion (CSII) is associated with increased hypoglycemia encounters and health care expenditures, according to research published in the American Journal of Managed Care (June 21,...
...
06/23/2017
Journal of Clinical Pathways
Department
Pazopanib More Cost-Effective Than Sunitinib for Patients With Renal Cell Carcinoma
04/12/2017
JCP Editors
Medicare patients with advanced renal cell carcinoma benefit from lower costs and hospital admissions if treated with pazopanib (Votrient, Novartis) rather than sunitinib (Sutent, Pfizer). Advanced renal cell...
Medicare patients with advanced renal cell carcinoma benefit from lower costs and hospital admissions if treated with pazopanib (Votrient, Novartis) rather than sunitinib (Sutent, Pfizer). Advanced renal cell...
...
04/12/2017
Journal of Clinical Pathways
Research in Review
Pazopanib Cost-Effective for Patients With Renal Cell Carcinoma
03/28/2017
JCP Editors
Medicare patients with advanced renal cell carcinoma benefit from lower costs and hospital admissions if treated with pazopanib rather than sunitinib, according to research presented at the AMCP Managed Care &...
Medicare patients with advanced renal cell carcinoma benefit from lower costs and hospital admissions if treated with pazopanib rather than sunitinib, according to research presented at the AMCP Managed Care &...
...
03/28/2017
Journal of Clinical Pathways
Research in Review
Lower Dosage of Prostate Cancer Drug Equally Effective When Taken With Low-Fat Meal
02/17/2017
JCP Editors
Taking one-fourth the recommended dose of a standard drug with a low-fat meal is as effective as taking the recommended dose on an empty stomach for patients with castration-resistant prostate cancer, according to...
Taking one-fourth the recommended dose of a standard drug with a low-fat meal is as effective as taking the recommended dose on an empty stomach for patients with castration-resistant prostate cancer, according to...
Taking...
02/17/2017
Journal of Clinical Pathways
Research in Review
Hormone Receptor-Negative Breast Cancers Gain Greatest Economic Benefit from Trastuzumab
12/13/2016
JCP Editors
The cost-effectiveness of adjuvant trastuzumab (Herceptin, Genentech) may vary based on patient age and disease subtype among women with HER2-positive breast cancer, according to study results published in PLoS...
The cost-effectiveness of adjuvant trastuzumab (Herceptin, Genentech) may vary based on patient age and disease subtype among women with HER2-positive breast cancer, according to study results published in PLoS...
The...
12/13/2016
Journal of Clinical Pathways
Research in Review
Trastuzumab Biosimilar Approval Could Improve Access to Treatment For Breast Cancer
12/05/2016
JCP Editors
The potential FDA approval of a new biosimilar to trastuzumab may help increase access to the treatment, which is recommended as first-line therapy for patients with ERBB2 (HER2)-positive breast...
The potential FDA approval of a new biosimilar to trastuzumab may help increase access to the treatment, which is recommended as first-line therapy for patients with ERBB2 (HER2)-positive breast...
The...
12/05/2016
Journal of Clinical Pathways
Perspectives
Frameworks for Assessing the Value of Cancer Drugs: Purely an Academic Exercise?
08/02/2016
Abstract: As the cost of prescription drugs increases, payers and providers alike have attempted to determine the value of treatments for high-cost disease, including cancer. In this article, the authors discuss the...
Abstract: As the cost of prescription drugs increases, payers and providers alike have attempted to determine the value of treatments for high-cost disease, including cancer. In this article, the authors discuss the...
...
08/02/2016
Journal of Clinical Pathways
Perspectives
Impact of Government Cost Controls on Treatment Selection for Clinical Pathways
03/08/2016
Abstract: The increasing emphasis on value-based care has led to the rise of clinical pathways and their use in various health care settings for a number of different disease states. To improve these pathways and...
Abstract: The increasing emphasis on value-based care has led to the rise of clinical pathways and their use in various health care settings for a number of different disease states. To improve these pathways and...
...
03/08/2016
Journal of Clinical Pathways
Partner Resource
Hillary Clinton`s Plan to Address Drug Costs: Experts Weigh In
10/25/2015
JCP Editors
Since Hillary Clinton announced her proposal to restructure American health care and take on the high costs of treatment, her plans have been met with no shortage of praise and criticism by experts within the health...
Since Hillary Clinton announced her proposal to restructure American health care and take on the high costs of treatment, her plans have been met with no shortage of praise and criticism by experts within the health...
Since...
10/25/2015
Journal of Clinical Pathways

Upcoming Events

February 2 ⁠–⁠ February 5
Western AF Symposium
February 27 ⁠–⁠ March 1
DCLF
March 17 ⁠–⁠ March 19
NP Institute
March 27 ⁠–⁠ March 30
TCIV
March 31 ⁠–⁠ April 2
Rx summit logo
April 21 ⁠–⁠ April 24
SAWC Spring
April 30 ⁠–⁠ May 4
Symposium on Advanced Wound Care
April 30 ⁠–⁠ May 5
WoundCon
May 1 ⁠–⁠ May 3
Senior Living Executive Conference
May 19 ⁠–⁠ May 21
See Full Calendar

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use